Typhoid vaccination: the Asian experience

被引：36

作者：

DeRoeck, Denise ^{[1
]}

Ochiai, R. Leon ^{[1
]}

Yang, Jin ^{[1
]}

Anh, Dang Duc ^{[1
]}

Alag, Vibha ^{[1
]}

Clemens, John D. ^{[1
]}

机构：

[1] Int Vaccine Inst, Social Sci Res & Inst Dev, Seoul 151818, South Korea

来源：

EXPERT REVIEW OF VACCINES | 2008年 / 7卷 / 05期

关键词：

Asia; China; immunization; India; Thailand; typhoid fever; vaccine; Vi polysaccharide vaccine; Vietnam; whole-cell killed typhoid vaccine;

D O I：

10.1586/14760584.7.5.547

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The WHO has recently issued updated recommendations for the programmatic use of new-generation typhoid vaccines in high-risk areas of countries where typhoid fever is still endemic. Countries have subsequently been instructed to discuss how these recommendations can be implemented and to develop plans for targeted typhoid vaccination. These plans can be informed by the experiences with typhoid vaccination that several Asian countries have had. This article reviews past and current typhoid vaccination programs that have taken place in Thailand (using the old whole-cell vaccine) and in China, Vietnam and India (using the new-generation injectable Vi polysaccharide vaccine). This review also describes recent typhoid Vi vaccine demonstration projects that were conducted in five Asian countries.

引用

页码：547 / 560

页数：14

共 30 条

[1] A multi-country cluster randomized controlled effectiveness evaluation to accelerate the introduction of Vi polysaccharide typhoid vaccine in developing countries in Asia: rationale and design [J].

Acosta, CJ ;

Galindo, CM ;

Ali, M ;

Abu Elyazeed, R ;

Ochiai, RL ;

Danovaro-Holliday, MC ;

Page, AL ;

Thiem, VD ;

Jin, Y ;

Park, JK ;

Lee, H ;

Puri, MK ;

Ivanoff, B ;

Agtini, MD ;

Soeharno, R ;

Simanjuntak, CH ;

Punjabi, NH ;

Canh, DG ;

Sur, D ;

Nizami, Q ;

Manna, B ;

Dong, BQ ;

Anh, DD ;

Yang, HH ;

Bhattacharya, SK ;

Bhutta, Z ;

Trach, DD ;

Xu, ZY ;

Pang, TK ;

Donner, A ;

Clemens, JD .

TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2005, 10 (12) :1219-1228

[2]

[Anonymous], 2008, Wkly Epidemiol Rec, V83, P49

[3]

[Anonymous], VACCINES

[4]

BODHIDATTA L, 1987, REV INFECT DIS, V9, P841

[5] Evaluating new vaccines for developing countries - Efficacy or effectiveness? [J].

Clemens, J ;

Brenner, R ;

Rao, M ;

Tafari, N ;

Lowe, C .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (05) :390-397

[6]

Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346

[7] Vaccines against typhoid fever [J].

Guzman, Carlos A. ;

Borsutzky, Stefan ;

Griot-Wenk, Monika ;

Metcalfe, Ian C. ;

Pearman, Jon ;

Collioud, Andre ;

Favre, Didier ;

Dietrich, Guido .

VACCINE, 2006, 24 (18) :3804-3811

[8]

IVANOFF B, 1994, B WORLD HEALTH ORGAN, V72, P957

[9] Trial participation and vaccine desirability for Vi polysaccharide typhoid fever vaccine in Hue City, Viet Nam [J].

Kaljee, Linda M. ;

Pham, Van ;

Son, Nguyen Dinh ;

Hoa, Nguyen Thai ;

Thiem, Vu Dinh ;

Canh, Do Gia ;

Kim Thoa, Le Thi ;

Ali, Mohammad ;

Ochiai, Rion Leon ;

Danovaro-Holliday, M. Carolina ;

Acosta, Camilo J. ;

Stanton, Bonita ;

Clemens, John .

TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2007, 12 (01) :25-36

[10] Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers [J].

Kirkpatrick, BD ;

McKenzie, R ;

O'Neill, JP ;

Larsson, CJ ;

Bourgeois, AL ;

Shimko, J ;

Bentley, M ;

Makin, J ;

Chatfield, S ;

Hindle, Z ;

Fidler, C ;

Robinson, BE ;

Ventrone, CH ;

Bansal, N ;

Carpenter, CM ;

Kutzko, D ;

Hamlet, S ;

LaPointe, C ;

Taylor, DN .

VACCINE, 2006, 24 (02) :116-123

← 1 2 3 →